Thomas Shaknovsky said in a deposition in November that he believed he was removing 70-year-old William Bryan’s spleen, not ...

TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic solutions.

Nicole Sganga is CBS News' homeland security and justice correspondent. She is based in Washington, D.C., and reports for all shows and platforms. A U.S. special forces soldier involved in the ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...

Pancreatic cancer is one of the deadliest cancers. It killed nearly 52,000 Americans last year, many within a year of diagnosis. Now, there are some new experimental medicines with the potential to ...

When former Nebraska Sen. Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by Revolution Medicines is giving him precious more ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

Reports suggest that Microsoft, one of the industry’s biggest customers, might be taking a step back. Last week, news outlets reported that Microsoft was pausing carbon removal purchases. It was ...

Once held up as a key solution to climate change, a field that aims to remove carbon from the atmosphere is struggling to catch on. By David Gelles David has been writing about carbon removal ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have plateaued in recent years. But two promising drugs in the pipeline ...